🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms withheld potential risks that the pain reliever created to pediatric neurological development.

The lawsuit comes thirty days after Former President Trump advocated an unsubstantiated connection between using acetaminophen - also known as paracetamol - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against Johnson & Johnson, which previously sold the drug, the sole analgesic suggested for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he stated they "betrayed America by profiting off of discomfort and marketing drugs without regard for the risks."

The company asserts there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies misled for generations, intentionally threatening countless individuals to increase profits," the attorney general, from the Republican party, said.

The manufacturer stated officially that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the health of US mothers and children."

On its official site, Kenvue also stated it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a proven link between using acetaminophen and autism spectrum disorder."

Groups speaking for medical professionals and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In multiple decades of studies on the utilization of acetaminophen in gestation, zero credible investigations has conclusively proven that the consumption of paracetamol in any stage of pregnancy results in neurological conditions in young ones," the association said.

The lawsuit cites current declarations from the former administration in claiming the medication is reportedly hazardous.

Recently, Trump raised alarms from public health officials when he instructed women during pregnancy to "fight like hell" not to use acetaminophen when sick.

The FDA then released a statement that medical professionals should think about restricting the consumption of acetaminophen, while also declaring that "a causal relationship" between the drug and autism in minors has not been proven.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had vowed in April to initiate "comprehensive study program" that would identify the source of autism spectrum disorder in a matter of months.

But experts warned that discovering a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would not be simple.

Autism is a category of permanent neurological difference and condition that affects how people encounter and relate to the world, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is running for US Senate - alleges the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The case attempts to require the companies "destroy any marketing or advertising" that asserts Tylenol is safe for women during pregnancy.

The court case parallels the grievances of a collection of guardians of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

Judicial authorities dismissed the lawsuit, declaring studies from the parents' expert witnesses was inconclusive.